| abstract |
Disclosed are methods of treating, preventing and / or managing myelodysplastic syndromes. Specific methods include the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof alone, or implantation of a second active ingredient and / or blood or cells And in combination with and administering. The specific second active ingredient can affect blood cell production. Also disclosed are pharmaceutical compositions, single unit dosage forms, and kits suitable for use in the methods of the invention. |